The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma.
DLG
DLG2
Isoform
L27
LIN7A
Neuroblastoma
Journal
Cancer cell international
ISSN: 1475-2867
Titre abrégé: Cancer Cell Int
Pays: England
ID NLM: 101139795
Informations de publication
Date de publication:
16 Mar 2021
16 Mar 2021
Historique:
received:
13
10
2020
accepted:
22
02
2021
entrez:
17
3
2021
pubmed:
18
3
2021
medline:
18
3
2021
Statut:
epublish
Résumé
Neuroblastoma is a childhood neural crest tumor showing large clinical and genetic heterogeneity, one form displaying 11q-deletion is very aggressive. It has been shown that 11q-deletion results in decreased expression of DLG2, a gene residing in the deleted region. DLG2 has a number of different isoforms with the main difference is the presence or absence of a L27 domain. The L27 domain containing DLG proteins can form complexes with CASK/MPP and LIN7 protein family members, which will control cell polarity and signaling. We evaluated the DLG gene family and the LIN7 gene family for their expression in differently INSS staged neuroblastoma from publically available data and primary tumors, we included two distinct DLG1 and DLG2 N-terminal transcript isoforms encoding L27 domains for their expression. Functionality of DLG2 isoforms and of LIN7A were evaluated in the 11q-deleted neuroblastoma cell line SKNAS. In neuroblastoma only two DLG2 isoforms were expressed: isoform 2 and isoform 7/8. Using the array data we could determine that higher expression of DLG members that contain L27 domains correlated to better survival and prognosis. Whilst DLG1 showed a decrease in both isoforms with increased INSS stage, only the full length L27 containing DLG2 transcripts DLG2-isoform 7/8 showed a decrease in expression in high stage neuroblastoma. We could show that the protein encoded by DLG2-isoform 7 could bind to LIN7A, and increased DLG2-isoform 7 gene expression increased the expression of LIN7A, this reduced neuroblastoma cell proliferation and viability, with increased BAX/BCL2 ratio indicating increased apoptosis. We have provided evidence that gene expression of the L27 domain containing DLG2-isoform 7/8 but not L27 domain lacking DLG2-isoform 2 is disrupted in neuroblastoma, in particular in the aggressive subsets of tumors. The presence of the complete L27 domain allows for the binding to LIN7A, which will control cell polarity and signaling, thus affecting cancer cell viability.
Sections du résumé
BACKGROUND
BACKGROUND
Neuroblastoma is a childhood neural crest tumor showing large clinical and genetic heterogeneity, one form displaying 11q-deletion is very aggressive. It has been shown that 11q-deletion results in decreased expression of DLG2, a gene residing in the deleted region. DLG2 has a number of different isoforms with the main difference is the presence or absence of a L27 domain. The L27 domain containing DLG proteins can form complexes with CASK/MPP and LIN7 protein family members, which will control cell polarity and signaling.
METHODS
METHODS
We evaluated the DLG gene family and the LIN7 gene family for their expression in differently INSS staged neuroblastoma from publically available data and primary tumors, we included two distinct DLG1 and DLG2 N-terminal transcript isoforms encoding L27 domains for their expression. Functionality of DLG2 isoforms and of LIN7A were evaluated in the 11q-deleted neuroblastoma cell line SKNAS.
RESULTS
RESULTS
In neuroblastoma only two DLG2 isoforms were expressed: isoform 2 and isoform 7/8. Using the array data we could determine that higher expression of DLG members that contain L27 domains correlated to better survival and prognosis. Whilst DLG1 showed a decrease in both isoforms with increased INSS stage, only the full length L27 containing DLG2 transcripts DLG2-isoform 7/8 showed a decrease in expression in high stage neuroblastoma. We could show that the protein encoded by DLG2-isoform 7 could bind to LIN7A, and increased DLG2-isoform 7 gene expression increased the expression of LIN7A, this reduced neuroblastoma cell proliferation and viability, with increased BAX/BCL2 ratio indicating increased apoptosis.
CONCLUSION
CONCLUSIONS
We have provided evidence that gene expression of the L27 domain containing DLG2-isoform 7/8 but not L27 domain lacking DLG2-isoform 2 is disrupted in neuroblastoma, in particular in the aggressive subsets of tumors. The presence of the complete L27 domain allows for the binding to LIN7A, which will control cell polarity and signaling, thus affecting cancer cell viability.
Identifiants
pubmed: 33726762
doi: 10.1186/s12935-021-01851-w
pii: 10.1186/s12935-021-01851-w
pmc: PMC7962242
doi:
Types de publication
Journal Article
Langues
eng
Pagination
170Subventions
Organisme : Barncancerfonden
ID : PR2019-0079
Organisme : Jane och Dan Olssons Stiftelse
ID : 2019-41
Références
J Biol Chem. 2007 Mar 30;282(13):9392-9400
pubmed: 17237226
Cancer Biol Ther. 2019;20(6):897-911
pubmed: 30862230
J Cell Physiol. 2019 Jul;234(7):10800-10808
pubmed: 30537154
J Neurosci. 2013 Sep 25;33(39):15504-17
pubmed: 24068818
Neuron. 2006 Jul 6;51(1):99-111
pubmed: 16815335
Histochem Cell Biol. 2019 Nov;152(5):333-343
pubmed: 31410570
PLoS One. 2016 Oct 5;11(10):e0163327
pubmed: 27706181
J Biol Chem. 2006 Feb 17;281(7):4267-73
pubmed: 16332687
J Neurosci. 2010 Apr 28;30(17):5811-24
pubmed: 20427642
J Neurosci. 2009 Apr 8;29(14):4332-45
pubmed: 19357261
J Vis Exp. 2010 Nov 26;(45):
pubmed: 22158024
EMBO J. 2004 Jul 21;23(14):2723-33
pubmed: 15241471
Breast Cancer Res. 2016 Feb 17;18(1):23
pubmed: 26887652
J Neurosci. 2010 Mar 31;30(13):4757-66
pubmed: 20357126
J Biol Chem. 2002 Feb 8;277(6):4477-84
pubmed: 11714708
Mol Biol Cell. 2009 Nov;20(21):4489-99
pubmed: 19726564
Cell Death Dis. 2018 May 10;9(5):535
pubmed: 29749382
Cell Rep. 2020 Sep 22;32(12):108171
pubmed: 32966799
Sci Rep. 2017 Feb 07;7:42125
pubmed: 28169360
Int J Biol Sci. 2014 May 03;10(5):543-9
pubmed: 24910533
Cell Death Dis. 2018 Apr 24;9(5):458
pubmed: 29686263
Nat Genet. 2013 Mar;45(3):279-84
pubmed: 23334666
Mol Cancer. 2017 Jun 29;16(1):114
pubmed: 28662712
J Biol Chem. 2005 Nov 18;280(46):38528-36
pubmed: 16147993
Cell Commun Signal. 2020 Apr 20;18(1):65
pubmed: 32312269
FEBS J. 2012 Oct;279(19):3549-3558
pubmed: 22846345
Clin Exp Pharmacol Physiol. 2019 Oct;46(10):937-943
pubmed: 31271664
J Neurosci. 1999 Jun 1;19(11):4189-99
pubmed: 10341223
J Neurophysiol. 2014 Feb;111(3):648-58
pubmed: 24225540
Front Mol Neurosci. 2019 Jan 29;12:9
pubmed: 30760980
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4323-8
pubmed: 20145112
Int J Cancer. 2000 May 15;86(4):480-8
pubmed: 10797259
Oncogene. 2019 Jan;38(2):291-298
pubmed: 30093633
PLoS One. 2014 Mar 21;9(3):e92695
pubmed: 24658322
J Neurosci. 2004 Jan 14;24(2):378-88
pubmed: 14724236
FASEB J. 2010 Dec;24(12):4806-15
pubmed: 20702775